At FDAs request, GSK is withdrawing the accelerated approval for Blenrep (belantamab mafodotin-blmf) due to the therapys poor showing in progression-f...
FDA approves Behrings Hemgenix to treat some adults with Hemophilia B.
FDA warns Lake Forest, CA-based Invitrx Therapeutics about illegally marketing cellular and acellular products and CGMP and CGTP violations in the man...
Federal Register notice: FDA makes available a final guidance entitled Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the ...
FDA reports on the latest three months of medical device reports on some Philips Respironics ventilators, BiPAP, and CPAP machines.
FDA announces a 1/26/2023 Webinar entitled FDAs Labeling Resources for Human Prescription Drugs that will discuss new resources available for the phar...
FDA updates a Web page it maintains on Medtronic recalls involving its HeartWare Ventricular Assist Device system that is intended to enhance user acc...
Federal Register notice: FDA corrects a 9/28 notice entitled Statement of Organization, Functions, and Delegations of Authority that discussed a reorg...